Published: 2017-05-23

A case of juvenile polymyositis post viral hepatitis A

Hanock Unni Samuel, N. V. Jayachandran, N. K. Thulaseedharan


Polymyositis is rare as a stand-alone entity and is often misdiagnosed; most patients whose condition has been diagnosed as polymyositis have inclusion-body myositis, necrotizing autoimmune myositis, or inflammatory dystrophy. Polymyositis remains a diagnosis of exclusion and is best defined as a subacute proximal myopathy in adults who do not have rash, a family history of neuromuscular disease, exposure to myotoxic drugs (e.g. statins, penicillamine, and zidovudine), involvement of facial and extraocular muscles, endocrinopathy, or the clinical phenotype of inclusion body myositis. The etiology of polymyositis may be due to underlying systemic autoimmune diseases, viral, parasitic, bacterial infections or drug induced. Here we describe a case of juvenile polymyositis post viral infection with hepatitis A.


Juvenile polymyositis, Post viral, Viral hepatitis A

Full Text:



Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362(9388):971-82.

Nojima T, Hirakata M, Sato S, Fujii T, Suwa A, Mimori T, et al. A case of polymyositis associated with hepatitis B infection. Clin Exp Rheumatol. 2000;18(1):86-8.

Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med. 1975;292(7):344-7.

Miller FW. Polymyositis, dermatomyositis. Clinical Primer of Rheumatology. Lippincott Williams and Wilkins; 2003:182-184.

Bohan A, Peter JB, Bowman RL, Pearson CM. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine. 1977;56(4):255-86.